Loading…
Medical Nutrition Equity Act of 2023
Legislative Progress
Introduced
December 22, 2023
Latest Action
December 17, 2024
Primary Sponsor
James P. McGovernDemocratic(MA)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
92pct
361d open
vs 10,564 other HR bills in the 118th — cohort avg 68d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (3)
2024 · fourth_quarter · Health Issues
Access to medically necessary foods and formulas for patients with gastrointestinal disorders and covered by Medicaid, CHIP, FEHBP or private health insurance plans; Medical Nutrition Equity Act (H.R. 6892) Support the Safe Step Act (S. 652 / H.R. 2630) which provides exceptions to step therapy protocols for ERISA health plans. Generally support pediatric access to biologic therapies and caution against removing interchangeability and biosimilar distinction among biological products. Oppose Biosimilar Red Tape Elimination Act (S. 2305) Improve pediatric indications for biologics (no specific legislation)
Referred to the Subcommittee on Health.
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Oversight and Accountability, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: Not reported · Firm income: $25,500
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Health Issues
Access to medically necessary foods and formulas for patients with gastrointestinal disorders and covered by Medicaid, CHIP, FEHBP or private health insurance plans; Medical Nutrition Equity Act (H.R. 6892) Support the Safe Step Act (S. 652 / H.R. 2630) which provides exceptions to step therapy protocols for ERISA health plans. Generally support pediatric access to biologic therapies and caution against removing interchangeability and biosimilar distinction among biological products.
Client expense: Not reported · Firm income: $25,500
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Health Issues
Medical Nutrition Equity Act (H.R. 6892)
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Health Issues
Rare Disease Initiatives. Newborn Screening. Affordable Care Act (ACA) Issues and Enhancements. Step Therapy. Telehealth. Priority Review Voucher Reauthorization. H.R.6892: Medical Nutrition Equity Act of 2023.
Client expense: $60,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Health Issues
Access to medically necessary foods and formulas for patients with gastrointestinal disorders and covered by Medicaid, CHIP, FEHBP or private health insurance plans; Medical Nutrition Equity Act (H.R. 6892) Support the Safe Step Act (S. 652 / H.R. 2630) which provides exceptions to step therapy protocols for ERISA health plans.
Client expense: Not reported · Firm income: $25,500
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Health Issues
Medical Nutrition Equity Act (H.R. 6892)
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Health Issues
Access to medically necessary foods and formulas for patients with gastrointestinal disorders and covered by Medicaid, CHIP, FEHBP or private health insurance plans; Medical Nutrition Equity Act (H.R. 6892) Support the Safe Step Act (S. 652 / H.R. 2630) which provides exceptions to step therapy protocols for ERISA health plans.
Client expense: Not reported · Firm income: $25,500
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Health Issues
Rare Disease Initiatives. Affordable Care Act (ACA) Issues and Enhancements. H.R.6892: Medical Nutrition Equity Act of 2023. H.R.2940/S.1355: PASTEUR Act. March-in Rights.
Client expense: $60,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institute of Standards & Technology (NIST), SENATE
2023 · fourth_quarter · Health Issues
Access to medically necessary foods and formulas for patients with gastrointestinal disorders and covered by Medicaid, CHIP, FEHBP or private health insurance plans; Medical Nutrition Equity Act (H.R. 6892) Support the Safe Step Act (S. 652 / H.R. 2630) which provides exceptions to step therapy protocols for ERISA health plans.
Client expense: Not reported · Firm income: $25,500
Government targets: HOUSE OF REPRESENTATIVES, SENATE
| House |
| Referred To |
| December 22, 2023 |
| Democratic |
| VA |
| Eleanor Holmes Norton | Democratic | DC |
| Joe Neguse | Democratic | CO |
| John H. Rutherford | Republican | FL |
| Katie Porter | Democratic | CA |
| Kim Schrier | Democratic | WA |
| Melanie A. Stansbury | Democratic | NM |
| Morgan McGarvey | Democratic | KY |
| Raja Krishnamoorthi | Democratic | IL |
| Sean Casten | Democratic | IL |
| Seth Moulton | Democratic | MA |
| Stephen F. Lynch | Democratic | MA |
| William R. Keating | Democratic | MA |
| Yvette D. Clarke | Democratic | NY |